BRIEF published on 04/07/2025 at 00:10, 1 year 1 month ago Sea Pharmaceuticals Partners with Inotiv to Develop CNS Treatments Sea Pharmaceuticals Inotiv Inc. SPM-0404 CNS Disorders Glutamate Pathway
PRESS RELEASE published on 04/07/2025 at 00:05, 1 year 1 month ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders Sea Pharmaceuticals announces partnership with Inotiv Inc. for development of potential neurotherapeutic medicine SPM-0404 to treat tinnitus, epilepsy, and ALS Sea Pharmaceuticals Inotiv Inc. SPM-0404 Neurotherapeutic Tinnitus
Published on 05/15/2026 at 14:35, 1 hour 25 minutes ago NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering
Published on 05/15/2026 at 14:30, 1 hour 30 minutes ago AIAI Holdings Corporation Expresses Appreciation to Revere Securities for Financial Advisory Support on Successful NASDAQ Direct Listing
Published on 05/15/2026 at 14:00, 2 hours ago CCL Industries Announces 2026 Annual and Special Shareholders' Meeting Results
Published on 05/15/2026 at 14:00, 2 hours ago First Canadian Graphite to Attend the Mining Investment Event in Quebec City
Published on 05/15/2026 at 15:35, 25 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 05/15/2026 at 15:33, 26 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 05/15/2026 at 15:08, 52 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/13/2026 at 17:45, 1 day 22 hours ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 1 day 22 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
Published on 05/13/2026 at 17:40, 1 day 22 hours ago Report on share repurchases from 6 to 12 May 2026
